SFA Therapeutics

Philadelphia, United States · Founded 2016 · $8.6M raised

Headquarters
Philadelphia
Employees
1–10
Founded
2016
Business Model
B2B
Total Funding
$8.6M
Last Round
$4.5M BridgeSep 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

SFA Therapeutics is creating therapeutically-tailored oral drugs that regulate the immune system, with a focus on autoimmune diseases and cancers that originate from chronic inflammation. Philadelphia-based SFA Therapeutics was founded in 2016 and came out of stealth mode in 2017, as a spinout from Temple University based on technology discovered by two biology professors. The company views itself as a product development company, taking candidates to proof of concept and then partnering in late-stage development, marketing, distribution, and commercialization with larger biopharmas.

Summary

SFA Therapeutics is a Biotech company based in Philadelphia, United States, founded in 2016. It has raised $8.6M in total across 2 rounds, most recently a $4.5M Bridge round in Sep 2023. Investors include North South Ventures, Acequia Capital and Boost VC.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

BridgeBridge RoundSep 2023
$4.5M

Sign up to see all 2 events

Funding: Seed through Bridge. Amounts, valuations, and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

SFA Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/sfa-therapeutics"><img src="https://indexed.vc/api/badge/company/sfa-therapeutics" alt="SFA Therapeutics on Indexed.vc" width="260" height="76" /></a>